2024-01-01 09911948 2024-12-31 09911948 2024-01-01 2024-12-31 09911948 2023-12-31 09911948 2023-01-01 2023-12-31 09911948 uk-core:WithinOneYear 2023-12-31 09911948 uk-core:WithinOneYear 2024-12-31 09911948 uk-core:AfterOneYear 2023-12-31 09911948 uk-core:AfterOneYear 2024-12-31 09911948 uk-bus:Director1 2024-01-01 2024-12-31 iso4217:GBP xbrli:pure 09911948 uk-bus:AuditExemptWithAccountantsReport 2024-01-01 2024-12-31 09911948 uk-bus:Micro-entities 2024-01-01 2024-12-31 09911948 uk-bus:FullAccounts 2024-01-01 2024-12-31 09911948 uk-bus:PrivateLimitedCompanyLtd 2024-01-01 2024-12-31
Earlybird Healthcare Group Ltd
Registered Number:09911948
For the year ended 31 December 2024
England and Wales
Unaudited Financial Statements
2
09911948
Registered Number :
As at 31 December 2024
Earlybird Healthcare Group Ltd
Statement of Financial Position and Notes to the Accounts
£
£
2023
2024
£
£
26,250
33,851
Current assets
Prepayments and accrued income
2,016
1,486
Creditors: amounts falling due
within one year
(22,499)
(22,544)
12,838
5,722
Net current assets
Total assets less current liabilities
5,722
12,838
Creditors: amounts falling due
after more than one year
(11,810)
(11,990)
(6,268)
Net assets/liabilities
1,028
(6,268)
1,028
Capital and reserves
Notes to the Accounts
Statutory Information
Earlybird Healthcare Group Ltd is a private limited company, limited by shares, domiciled in England and Wales,
registration number 09911948.
Registered address:
572 Ipswich Road
Colchester
CO4 9HB
The presentation currency is £ sterling.
1. Average number of persons employed
During the year the average number of employees was 0 (2023 : 3)
1 of 2
3
09911948
Registered Number :
For the year ended 31 December 2024
Earlybird Healthcare Group Ltd
Statement of Financial Position and Notes to the Accounts Continued
For the year ended 31 December 2024 the company was entitled to exemption from audit under Section 477 of the Companies Act 2006 relating to small companies.
The members have not required the company to obtain an audit of its financial statements for the year ended 31 December 2024 in accordance with Section 476 of the Companies Act 2006.
The directors acknowledge their responsibilities for:a) ensuring that the company keeps proper accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
b) preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of
each financial year and of its profit or loss for each financial year in accordance with the requirements of Section
394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial
statements, so far as applicable to the company.
These financial statements have been prepared in accordance with the micro-entities provisions and delivered in accordance with the provisions applicable to companies subject to the small companies regime.
A Mapira Director
These financial statements were approved and authorised for issue by the Board on 25 March 2025 and were signed by:
2 of 2